"Harbin Clinic Cancer Center is a hub for all of your cancer care needs, uniting our community in the fight against cancer. The beginning of a cancer journey is full of unknowns, and our job is to help you be prepared."

During the past decade, Harbin Clinic Medical Oncology and Clinical Research conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 51 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 21 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Harbin Clinic Medical Oncology and Clinical Research" #1 sponsor was "SWOG Cancer Research Network" with 28 trials, followed by "National Cancer Institute (NCI)" with 25 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "NSABP Foundation Inc" with 5 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harbin Clinic Medical Oncology and Clinical Research" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "North Central Cancer Treatment Group" with 6 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Harbin Clinic Medical Oncology and Clinical Research" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Breast Cancer" (7 trials), "Lung Cancer" (6 trials), "Lymphoma" (6 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials). Many other conditions were trialed in "Harbin Clinic Medical Oncology and Clinical Research" in a lesser frequency.

Most popular intervention types in "Harbin Clinic Medical Oncology and Clinical Research" are "Drug" (56 trials), "Other" (53 trials), "Biological" (31 trials), "Procedure" (8 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (32 trials), "Paclitaxel" (11 trials), "Quality-of-Life Assessment" (11 trials), "Bevacizumab" (10 trials) and "Carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Harbin Clinic Medical Oncology and Clinical Research" are 57 trials for "All" genders, 14 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Harbin Clinic Medical Oncology and Clinical Research". undefined are not yet recruiting, 3 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Harbin Clinic Medical Oncology and Clinical Research, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Harbin Clinic Medical Oncology and Clinical Research, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".